-
17 injured, five critically, in head-on train crash in Denmark
-
Iran economy looks set to withstand US naval blockade
-
EssilorLuxottica sales slide as investors turn wary of AI glasses
-
Lufthansa loses fight over bailout at EU top court
-
Eurozone business activity falls on Mideast war
-
Leipzig and Union's Bundesliga clash shows changing face of football
-
Trump envoy wants Italy to replace Iran at World Cup: report
-
Electric vehicles supercharge EU car sales
-
Starc cleared to play in IPL by Cricket Australia
-
South Korea e-commerce probe opens rift in US ties
-
Clearing Hormuz Strait mines could take six months: report
-
South Korea's Samsung workers rally in thousands as strike looms
-
US firms voice 'concern' over China's new supply chain rules
-
Iran says won't reopen Hormuz if US upholds naval blockade
-
Japanese team with school coach to cap remarkable journey to the top
-
UN leadership hopefuls stress need for peace and restoring confidence
-
France must avoid becoming 'hostage' on critical minerals: trade minister
-
Thunder roll past Suns, Pistons bounce back to level series with Magic
-
US says China used 'intimidation' to block Taiwan leader's Africa trip
-
Suarez off mark but Messi fires blanks as Miami beat Salt Lake
-
Inter ready to pounce for Serie A title glory as Milan host Juve
-
Fresh paint, careful choreography as pope visits African prison
-
Jones calls on Australian fans to get behind Japan at World Cup
-
Sellers in China trade hub seek tariff reprieve from Trump visit
-
Stocks sink and oil rises with Iran, US no closer to peace talks
-
'Dancing in their hands': Japan wig masters set stage alive
-
Climate scrubbed from G7 meeting to appease US, host France says
-
Trump, his 'low IQ' slur, and the right's race obsession
-
FireFox Gold Provides Update on Kolho Joint Venture Lapland, Finland
-
American Critical Minerals Engages RESPEC to Execute Its 2026 Drill Program at Green River Project
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 23
-
Akkodis Named a Leader in ISG Provider Lens(TM) Digital Engineering Services 2026 Reports
-
Sun N Fun Pool & Spa Wins 2026 Consumer Choice Award for Swimming Pool Contractors, Dealers, Designers in Central Alberta
-
Institutional Digital Asset Infrastructure: The Maturation of Yield Routing and Restaking Rails
-
Chip giant SK hynix posts record quarterly profit on AI boom
-
Tesla reports higher profits, confirms hefty spending ahead
-
'Big loss' for F1 if Verstappen quits, say McLaren rivals
-
Israeli strikes kill 5 in Lebanon, Beirut to seek truce extension
-
Barca edge Celta but lose match-winner Yamal to injury
-
UK, France agree three-year deal to stop migrant crossings
-
Trump looks for way out on war, but Iran may not oblige
-
Tears and smiles at tribute concert for Swiss fire victims
-
Tesla reports higher profits, topping estimates
-
Manchester City go top of Premier League as Burnley relegated
-
Kane and Diaz send Bayern past Leverkusen into German Cup final
-
Concert pays tribute to Swiss fire disaster victims
-
US stocks rise, shrugging off uncertain ceasefire prospects while oil prices jump
-
Pope hits out at jails in closed-off Equatorial Guinea
-
Atletico beaten again in Elche thriller
-
England rugby great Moody offered 'hope' in battle with motor neurone disease
Featured
Last news
Kaye Allene Allen: Faith, Resilience, and Speaking to the Next Generation
Beyond the Manuscript Evrima Chicago
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK populationThe facility marks a cornerstone of Moderna's ten-year strategic partnership with the UK Government, designed to strengthen health resilience and drive economic growth
Aytu BioPharma to Present at Upcoming September 2025 Conferences
DENVER, CO / ACCESS Newswire / September 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced management will participate at the following investor conferences:
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the significant responder analysis results for crofelemer in the prespecified subgroup of patients with breast cancer from the OnTarget study that were reported at the Multinational Association of Supportive Care in Cancer 2025 Annual Meeting and the 2024 San Antonio Breast Cancer Symposium
TruMerit and EnGen Partner to Equip Foreign-Educated Health Professionals With English Skills for Success in Work and Life
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 24, 2025 / TruMerit, a leader in global healthcare workforce development, is partnering with EnGen, a workforce-aligned English language learning solution, to support foreign-educated nurses and other healthcare professionals in building the language skills to succeed in English-speaking work environments and to flourish in their new communities.
Claudia Cardinale: single mother who survived rape to be a screen queen
Sixties screen siren Claudia Cardinale, who died on Tuesday aged 87, entranced audiences across the globe with the sultry gaze that made her the muse of Luchino Visconti and Federico Fellini.
Four years in prison for woman who plotted to sell Elvis's Graceland
A Missouri woman was sentenced to more than four years in prison on Tuesday for an outlandish plot to steal ownership of Graceland, the historic home of Elvis Presley, from the family of the King of Rock and Roll and put it up for auction.
Turkey facing worst drought in over 50 years
Turkey is experiencing its worst drought in over half a century, with rainfall dropping by 27 percent compared to the last three decades and even more in some regions, according to data published this week.
Denmark brands mystery drone flights 'serious' attack
Large drones that flew over Copenhagen airport for hours and caused it to shut down constituted the "most serious attack on Danish critical infrastructure" to date, Prime Minister Mette Frederiksen said Tuesday.
Drone flights 'most serious attack' on Danish infrastructure, PM says
Large drones that flew over Copenhagen airport for hours and caused it to shut down constituted the "most serious attack on Danish critical infrastructure" to date, Prime Minister Mette Frederiksen said Tuesday.
India bids tearful farewell to maverick musician
Tens of thousands of mourners thronged the streets of India's northeastern Assam state on Tuesday to bid farewell to a flamboyant artiste, celebrated as much for his music as for his irreverent persona.
Unification Church leader arrested in South Korea
The Unification Church leader was arrested Tuesday in South Korea over allegations of bribery linked to a former first lady, including luxury gifts, prosecutors said.
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term Revenue Opportunity
Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has initiated the official approval process for its new product PulmoPlas® with the Federal Institute for Drugs and Medical Devices („Bundesinstitut für Arzneimittel und Medizinprodukte"; BfArM). With this step, the company is setting the course for the future widespread use of this novel therapy.
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025.
Medical Care Technologies Inc. Introduces AI Facial Health Risk Estimator for Cardiovascular Disease Detection
MESA, ARIZONA / ACCESS Newswire / September 23, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of its AI Facial Health Risk Estimator, a groundbreaking technology that leverages advanced facial imaging to provide early risk detection for cardiovascular disease, one of the leading causes of death worldwide.
Nepra Foods Inc. Announces Exclusive North American Distribution Agreement for Award-Winning Naki Manuka Honey
VANCOUVER, BC / ACCESS Newswire / September 23, 2025 / Nepra Foods Inc. (CSE:NPRA)(OTCQB:NPRFF)(FSE:2P6) ("Nepra" or the "Company"), a pioneer in specialty and allergen-free food innovations driving healthier futures, announces an exclusive agreement between Nepra Foods Ltd. and Naki New Zealand, a premier family-owned producer of Unique Manuka Factor (UMF) certified Manuka honey. This strategic partnership positions Nepra as the sole North American distributor and sales team for Naki's Manuka honey products starting in Q4 2025. Further contract details remain confidential.
Viemed Healthcare Announces Completion of Share Repurchase Program
LAFAYETTE, LA / ACCESS Newswire / September 23, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases authorized under its previously announced share repurchase program.
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
Full year fiscal 2025 net revenue of $66.4 millionFull year fiscal 2025 net loss of $13.6 millionFull year fiscal 2025 adjusted EBITDA1 of $9.2 million$31.0 million cash balance at June 30, 2025Exclusive agreement in June 2025 to commercialize EXXUA™ (gepirone) extended-release tablets ("EXXUA") is expected to serve as a major growth catalyst; the Company anticipates launching EXXUA in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") market with what the Company believes to be a novel first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDDCompany to host conference call and webcast today, September 23, 2025, at 4:30 p.m. Eastern time
Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions
BOSTON, MA / ACCESS Newswire / September 23, 2025 / MEDevice Boston, the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote speakers for the 2025 conference. The event will take place September 30 - October 1, at the Boston Convention & Exhibition Center (BCEC). This year's keynote sessions will feature prominent thought leaders in healthcare advancements and device development, sharing insights on the future of MedTech and strategies for success in an evolving healthcare landscape.
42WEST, a Subsidiary of Dolphin, Drives Global Reveal of 30 Ninjas' Asteroid – Backed by Google's Android XR and CAA
Directed by Doug Liman, the Film Premiered in the Venice Immersive Competition at the 82nd Venice International Film Festival
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / September 23, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, September 25, 2025 at the Emerging Growth Conference and virtually on Tuesday, September 30, 2025 at the Lytham Partners Fall 2025 Conference.
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences
STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical teams will be in attendance at upcoming industry conferences and present posters that underscore the Company's flexible nucleic acid production solutions designed to meet critical unmet needs for the manufacture of advanced biotherapeutics:
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groupsBoth of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
LiberNovo North American Pre-Sales Now Live With the First Dynamic Ergonomic Chair
From September 23 at 7:00 PM PDT through October 20, U.S. and Canadian customers can reserve Omni with an exclusive 5% new-customer discount (limited quantities) and receive a complimentary gift pack: eye mask, eco-bag, and foot cushion. Shipping begins October 20.
Brag House and New to The Street Exploring Strategic Collaboration
NEW YORK, NY / ACCESS Newswire / September 23, 2025 / New to The Street, one of the fastest-growing financial media brands with over 3.5 million YouTube subscribers and weekly national broadcasts on Fox Business and Bloomberg, announced today it is in discussions with Brag House, a Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, to explore a potential strategic collaboration.
S. Korea court issues arrest warrant for Unification Church leader: Yonhap
A Seoul court on Tuesday issued an arrest warrant for Unification Church leader Han Hak-ja over allegations of bribery linked to a former first lady and incitement to destroy evidence, the Yonhap news agency reported.
UK charities axe Prince Andrew's ex-wife over Epstein email
Numerous UK charities Monday severed ties with Sarah Ferguson, the ex-wife of disgraced Prince Andrew, after a new email emerged in which she called convicted US sex offender Jeffrey Epstein a "supreme friend" and sought forgiveness for "letting him down".
Jews flock to Ukraine for New Year pilgrimage despite travel warning
Thousands of Orthodox Jews flocked to the Ukrainian city of Uman on Monday for the celebration of Rosh Hashanah, despite warnings from Kyiv not to travel due to the Russian invasion.
UK charity axes Prince Andrew's ex-wife over Epstein email
A UK children's charity said Monday that it had severed ties with Sarah Ferguson, the ex-wife of disgraced Prince Andrew, after an email emerged between her and convicted US sex offender Jeffrey Epstein.